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This paper reviews the correlations and potential links 
between health and economic growth and summarizes 
the evidence on the role of government in improving 
health status. At the macroeconomic level, the evidence 
of an impact of health on growth remains ambiguous 
due both to difficulties in measuring health, and to the 
methodological challenges of identifying causal links.
   The evidence on the micro linkages from health 
investments to productivity and income are robust. 
Progress in life expectancy over the past two centuries 
has been spectacular, fueled by: improved agriculture 
that has increased food quantity; knowledge of disease 
transmission, and effective public health interventions 
that have controlled communicable diseases such as 
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on the Web at http://econ.worldbank.org. The author may be contacted at mlewis1@worldbank.org.  
malaria, yellow fever, and hookworm; and, most recently 
and importantly, investments in very young children that 
pay off in healthier and more productive adults.
   Whether public investments in medical care affect 
health hinges on the quality of health institutions.  In 
much of the developing world, factors such as chronic 
absenteeism among public providers, poor budget 
execution, ineffective management, and virtually no 
accountability weaken public efforts. Institutional 
issues are central in efforts to enhance public health 
investments, which in turn have a direct impact on the 
population’s welfare and, perhaps over the long term, 
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and Erika Mae Lorenzana provided expert research assistance. The authors alone are responsible 
for the content of this paper.  The findings, interpretations, and conclusions are the authors’ own 
and should not be attributed to the World Bank, its Executive Board of Directors, or any of its 
member countries. Improvements in health status over the last 50–100 years, as measured by a number of indicators, 
have been nothing short of spectacular. Vaccines, antibiotics, and other pharmaceutical 
developments have drastically reduced the incidence of illness and death. Economic growth has 
also helped: richer people are better nourished and educated, and richer countries are more able 
to afford the public goods (such as supply of water and sanitation and control of disease vectors 
such as mosquitoes) that reduce the transmission of disease.  
 
Do improvements in health themselves help to boost economic growth? This proposition is at the 
heart of the report of the World Health Organization’s Commission on Macroeconomics and 
Health (WHO 2001: i), which states, “Extending the coverage of crucial health services … to the 
world’s poor could save millions of lives each year, reduce poverty, spur economic development, 
and promote global security.” According to this view, better health care may be able to 
accomplish what development practitioners, nongovernmental organizations (NGOs), 
economists, foreign aid, and diplomacy have failed to achieve. Some researchers who have found 
a significant link from health to growth (for example, Bloom and Canning 2003a, 2003b) have 
used this finding to argue for large increases in government spending on health.  
 
Both directions of causality between health and income are likely operative, although they are 
difficult to measure and estimate, and a vigorous ongoing debate about which direction 
dominates reflects these empirical challenges. A resolution of this debate could boost the 
urgency of the quest for growth, inform that quest, or both. For example, a finding that economic 
growth reduces infant mortality could hasten the adoption of potentially growth-enhancing 
policy reforms. Alternatively, if better population health were found to stimulate economic 
growth, the full social returns to policies that directly improve health status would be higher than 
is now recognized, and interventions designed to improve health might be added to the armory of 
growth-friendly policies to be used in the quest for growth. 
 
To help inform decision making on public policy, this review examines the routes by which 
improvements in health might indeed increase incomes and growth and the related evidence. 
Recent advances in the literature suggest that a link from health to growth may be operational, 
but difficult to measure, and that its effect is likely to be relatively small. 
 
Better health may lead to income growth, but this does not necessarily mean that governments of 
developing countries should spend more of their budgets on health care. As Bloom and Canning 
(2003a: 313) point out, “The key issue is not that spending on health would be good [although 
some authors question even this assumption], it is whether spending on health is better than other 
uses of the limited funds available in developing countries.” Public spending on health care 
might not be the best way to achieve health, let alone growth. 
 
Thus a second goal of our review is to investigate the determinants of health itself, particularly 
the evidence on the impact of public expenditure policies on health. Some specific public 
interventions seem to be very good for health outcomes, while some broader measures seem to 
have little measurable effect. But overall there appears to be growing evidence that public 
policies only improve health when institutions are of sufficiently high quality and that good 
institutions themselves are likely to have a more important direct effect on growth than on 
growth-through-health.  
  2 
We caution the reader against expecting to find consensus in the empirical literature on the links 
from health to growth or even from health policies to health. A number of papers present 
unambiguous results but contradict one another. From our reading, the literature is a mix of 
rigorous scientific investigation and well-motivated advocacy on both sides.
1 Further, when 
attempting to untangle the link from health to growth, or vice versa, econometric issues of 
endogeneity and measurement error are particularly problematic, and the validity of even the 
most innovative approaches continues to be debated.  
 
Health status is affected by food and nutrition, public health investments, and individual medical 
services. In addition, other factors, notably cognitive and noncognitive educational attainment, 
deeply affect the predisposition to illness and the ability to ward off and manage illness in 
adulthood. We review the evidence surrounding all of these influences to gain some appreciation 
of the link between a country’s investments in “health” and economic growth.  
 
The first section of this paper examines the links between health outcomes and economic growth 
at the macro level, encompassing discussion of the econometric and policy issues. Then, because 
the health-income literature provides little policy guidance on how to improve health, the second 
section reviews the microeconomic linkages between health and income and considers the 
crucial role that public investments outside the “health” sector have played in improving health 
status. The third section summarizes the weak links between investments in medical care and 
health status and discusses the institutional challenges within the health sector if investments in 
health care are to improve health. A final section concludes. 
 
 
Population Health and Income: Potential Links and Evidence 
 
This section provides an overview of the historical patterns of health improvements as 
background to a review of the mechanisms by which improvements in a population’s health 
might lead to increases in income. We then present some basic evidence on the associations 
between trends in health and trends in national income, across countries and within two large 
developing countries (China and India) over time, and discuss the challenges faced in 
interpreting these associations.  
 
How Did We Get So Healthy? 
 
This historical overview details the main causes of improvements in population health, many of 
which, such as improvements in food supply, sanitation, and control of disease vectors, lie 
outside the health care field.  
 
The dramatic improvements in health status of the past 50 years—most obvious from the 
declines in mortality and increases in life expectancy—stem mainly from improvements in 
                                                 
11. As Dixit (2006: 23) notes in a thought-provoking discussion, conflicting research findings in the growth and 
development literature “can leave a user who is not an expert in a particular area in a thorough state of confusion and 
indecision.” 
  3nutrition, advances in public health, and education; for populations at large, higher spending on 
health care has had minimal impacts on mortality.  
 
Historically, inadequate food production and the resulting malnutrition compromised adult 
productivity. For example, data from the United Kingdom show that, until the late eighteenth 
century, U.K. agricultural production could only feed 80 percent of the population. Greater 
output raised nutritional status, leading to longer working hours, while parallel investments in 
public health improved the use of the calories consumed (Fogel 2002). Fogel (1986) concludes 
that nutritional improvements have contributed about 40 percent to the decline in mortality since 
1700, with sharp rises in nutritional status occurring in periods of abundant food, mostly in the 
twentieth century.  
 
Along with better nutrition, advances in hygiene and education have played a more important 
role in reducing mortality than advances in medicine. McKeown, Record, and Turner (1962, 
1975) examine the reasons for mortality declines in England and Wales during the nineteenth 
and twentieth centuries. Mortality was affected by medical measures such as immunizations, but 
lower exposure to infection, expanded access to piped water and sanitation, and better nutrition 
were the major factors explaining the rising survival rate. Reduction in death from air-borne 
infections occurred before the introduction of effective medical treatment, and better nutrition 
had a large effect on the ability to ward off infection and on the probability of death. Declines in 
mortality from water- and food-borne diseases could be traced to improved hygiene and better 
nutrition, with treatment emerging as largely irrelevant.  
 
Similarly, Fuchs (1974), in his study of infant mortality reductions in New York City between 
1900 and 1930, attributed these shifts mainly to rising standards of living, education, and lower 
fertility, rather than to medical advances. Fogel (2002) compares morbidity levels in the post–
Civil War period in the United States with those in the latter part of the twentieth century and 
finds that morbidity levels have fallen significantly, partly because of changes in lifestyle and 
partly because of other factors including medical interventions. Lleras-Muney (2005) examines 
the determinants of life expectancy in the United States using a synthetic cohort beginning in 
1900. Her estimates indicate that each year of education increases life expectancy at age 35 by as 
much as 1.7 years, a very significant increase that suggests the central importance of education. 
Similar findings are reported in multiple studies in developing countries (Schultz 2002). 
 
Exceptions are breakthroughs in pharmaceutical therapies after the 1940s—notably vaccines, 
penicillin, and other antibiotics that penicillin spawned—that changed the health landscape. 
Acemoglu and Johnson (in Spence and Lewis, forthcoming) also point to the development of the 
pesticide DDT, which effectively controlled disease vectors like mosquitoes, and to the 
establishment of the World Health Organization, which helped to spread knowledge about, and 
methods for, the adoption of technologies that helped to reduce mortality. The contribution of 
medical advances to either morbidity or mortality is more difficult to trace and to attribute 
directly. This is because it is difficult to isolate the effect of individual procedures, whose 
successful application depends on many factors.
2 
                                                 
2. Limited data for specific interventions, differences in patients’ health when treated, and high variability in the 
medical treatment across medical facilities that complement and influence successful application of new medical 
technologies, among other things, make it difficult to determine the contribution of new medical procedures. Cost-
  4 
More recent evidence from the Organisation for Economic Co-operation and Development 
(OECD) countries suggests that changes in lifestyle and nonmedical advances have had a bigger 
impact than medical advances and health care on longevity and well-being. Lifestyle changes 
such as reduced cigarette smoking and more moderate alcohol consumption have made the U.S. 
population healthier (Wolfe 1986).  
 
Both in OECD countries and in China, many of the most effective therapies for infectious 
diseases only emerged after the improvements in public health were well established. In their 
examination of the declines in infectious diseases in the United States over the period 1900–73, 
McKinley and McKinley (1997), like other researchers, find that effective treatments emerged 
only after the incidence of these diseases had fallen; nonmedical factors had played important 
roles in reducing morbidity and mortality from those diseases. China has historically shown 
much better health indicators than its income might predict. Although much of this achievement 
was popularly attributed to the country’s barefoot doctors—minimally trained medical personnel 
who were tasked with providing primary health services—most of the improvements in infant 
and child mortality occurred before the barefoot doctors began to be deployed in 1965; after the 
barefoot doctor system was abandoned, China’s health status did not decline. The early health 
improvements can be credited to, among other things, Chairman Mao’s “five pests” campaign, 
his exhortation to drink tea instead of (unboiled) water, and China’s generally safe latrines. 
Figure 1 illustrates the lack of evidence linking barefoot doctors to health improvements.  
 


















    Source: Hsiao 1984.  
                                                                                                                                                             
effectiveness studies have shed light on some procedures, but controversy persists about the value of medical 
advances in terms of additional years of life. For example, Cutler (2007) examines the cost-effectiveness of 
therapeutic surgical care after a heart attack and concludes that it is not clear whether the benefits of 
revascularization are due to the procedure itself or to the other services that are associated with care at hospitals with 
the capacity to offer these services. Unlike the pharmaceutical and vector control innovations, the contribution of 
medical advances remains controversial. 
  5    Note: The curved arrow and associated text have been added to the original.  
 
Underlying the health improvements that countries achieved were investments informed by 
advances in public health science. Periodic epidemics of cholera, malaria, and other infectious 
diseases plagued Europe and the Americas during the nineteenth century until the science of 
disease transmission developed and viable interventions were discovered. Major investments in 
public health in the nineteenth century—in response to the work of Snow (1849) linking 
contaminated water with cholera—resulted in dramatic declines in mortality. Simply eliminating 
people’s contact with sewage-contaminated water contained the cholera epidemic in London in 
1854 (Crossier 2007). Similarly, the Thames embankment, which helped the river to move 
effluent out of London, and the draining of swamps elsewhere led to the disappearance of 
malaria in the United Kingdom (Kuhn and others 2003). More recently, Cutler and Miller (2005) 
have studied the impact of clean water on health, looking at the results of the adoption of 
filtration and chlorination by U.S. cities in the first quarter of the twentieth century. They 
attribute nearly half of the total reduction in mortality in major cities, three-quarters of the 
reduction in infant mortality, and two-thirds of the reduction in child mortality to improved water 
supply.  
 
An important factor that facilitated the introduction of public health measures was centralized 
decision making with little involvement of citizens, driven by economic imperatives. Eminent 
domain effectively ensured that public health measures in Europe and parts of the Americas were 
implemented before the twentieth century. Beginning in the mid-nineteenth century in the 
Americas, concerns about contagious tropical illness such as yellow fever, cholera, and malaria 
prompted the region’s governments to adopt the Pan American Sanitary Code, which entailed the 
adoption of intense disease surveillance and reporting, control of disease vectors, sanitary 
improvements, and significant investments in parasitology research centers across Latin America 
to limit quarantine-related and other delays to regional trade (PAHO 1999). A recent example of 
collective action to enhance human and economic well-being is the multicountry- and 
multidonor-funded Onchocerciasis (river blindness) Control Program in the Niger delta in West 
Africa. The program of spraying infected areas with pesticide has effectively controlled the black 
flies responsible for this debilitating and lethal human infection. It has enabled the recultivation 
of 25 million hectares of fertile agricultural land, which had been abandoned because of the 
prevalence of the disease (Benton 2001).  
 
Other such public health interventions are needed across the developing world to deal with some 
of the same challenges that confronted European cities in earlier times. The World Bank 
estimates that a billion people lack access to clean water and 2.6 billion (or roughly 40 percent of 
the world’s population) lack access to basic sanitation. Some 94 percent of diarrheal cases 
worldwide can be attributed to unsafe drinking water, poor sanitation, and inadequate hygiene, 
with 1.5 million cases resulting in death, mostly among children (World Bank 2008). The 
importance of these basic public health measures to promoting good health and reducing 






  6How Might Health Make You Rich?  
 
The most obvious reason why healthier people might be richer is that they can work harder, 
longer, and more consistently than others. In turn, those who are disabled or ill can work less, 
placing an economic burden on the household. But can better health increase the rate at which 
income grows?  
 
Human Capital Accumulation 
 
A recurring theme in the literature is that health leads to income growth through its effect on 
human capital accumulation—and particularly through education—provided that people have 
sufficient food and satisfactory educational opportunities.  
 
First, children who are healthy and adequately nourished may spend more time at school and be 
better learners while there, preparing themselves to earn higher incomes. Along these lines, 
Sachs and Malaney (2002) describe a number of channels through which malaria can 
compromise educational attainment, including by hampering fetal development, reducing 
cognitive ability, and lowering school attendance.  
 
Second, the health status of adults affects human capital accumulation by their children. A large 
proportion of human capital investment decisions are made by parents on their children’s behalf. 
But if parents die, they cannot invest in their children. Orphans do not necessarily suffer a 
complete withdrawal of adult support, given the social networks in many societies, but they are 
likely to receive less than when their parents were alive, an issue that is discussed below in the 
context of the economic impact of illness. Lorentzen, McMillan, and Wacziarg (2005), using an 
instrumental variables approach, find that the adult mortality rate affects growth less through its 
influence on investments in education than through its influence on fertility and physical capital 
investments. 
 
Physical Capital Accumulation  
 
A population in better health may accumulate physical capital more quickly. The most obvious 
route is through savings, as higher life expectancy (for example) increases the expected length of 
retirement. Indeed, Bloom, Canning, and Graham (2002) attribute the rapid growth of East Asia 
to precisely this mechanism. Alsan, Bloom, and Canning (2006) and Sachs and Malaney (2002) 
highlight the impact that better population health has on inflows of foreign capital, as opposed to 
increases in domestic savings; this effect is usually thought to operate in situations in which 
foreign (direct) investment and expatriates (either in the role of staff or consumers) are highly 
complementary. Tourism is the most commonly cited example, as the threat of communicable 
diseases such as SARS (severe acute respiratory syndrome) deters visitors and investment, at 
least in the short term, because it suggests high-risk environments (Bell and Lewis 2004).  
 
Trends in Health and National Income  
 
The economics and population-health professions were brought together empirically only in the 
last 30 years. Preston (1975) presents data on per capita income and on population health status 
  7as measured by life expectancy for a cross section of countries. More recent data confirm his 
finding of a concave relationship between health status and income (see Figure 2) and show that 
this relationship is becoming stronger over time. 
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                            Source: World Bank, World Development Indicators. 
  8This latter fact shows that income, as measured by GDP, cannot be the sole determinant of 
health; if it were, countries that grew richer over time would simply have moved along the curve 
defined by a given year’s cross-sectional data. On average, countries whose incomes have grown 
have achieved better health improvements than would have been predicted from the 1975 data. 
 
The concave relationship between income and health suggests the importance of income 
distribution for a country’s health status: in a country with highly unequal income distribution, 
the population at large is likely to be less healthy than would be predicted for countries with the 
same average income. It is commonly argued that this relationship provides a rationale for 
redistributing a country’s income from rich to poor citizens, so as to raise average health status 
while keeping average income constant (ignoring the efficiency costs of redistribution). This 
sounds reasonable if indeed increasing the incomes of the poor will improve their health. 
However, if one believes that changes in health drive income growth, the same concavity 
properties imply that redistributing health from the unhealthy to the healthy (that is, in the 
“wrong” direction) would increase aggregate income, with no effect on average health status. 
The validity, if not the desirability, of each of these interventions thus depends crucially on the 
direction of causality between income and health.  
 
Figure 3. Normalized Cross-Country Standard Deviations 
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               Source: Deaton 2006.  
Note: The infant mortality rate (IMR) measures the number of children born who die before  
their first birthday per 1,000 births. The standard deviation of the under-five mortality rate shows 
a similar evolution and is not presented in this figure. The IMR is a significant factor in life  
expectancy calculations, because, particularly in countries with high death rates, the majority of a  
country’s deaths occur in the first year of life. 
  9Although the Preston curve shows a close relationship between income and health in the cross-
sectional data, longitudinal data suggest that this relationship may not hold within individual 
countries over time. Figure 3 draws on data presented by Deaton (2006) on the evolution of the 
cross-country distribution of national incomes and health status between 1960 and 2004. Each 
curve represents the standard deviation of a variable relative to its value in 1960. The figure 
shows that per capita incomes have steadily diverged, in keeping with the well-established 
evidence that incomes in poor countries have not grown fast enough to catch up with incomes in 
richer countries (Commission on Growth and Development 2008; Pritchett 1997). By contrast, 
country-level health indicators have converged—until 1990 for life expectancy and through 2004 
for the infant mortality rate.
3  
 
Thus Figure 3 suggests that, over time, changes in income seem to be unrelated, or even 
negatively related, to changes in health status: incomes have continued to diverge, while health 
status has converged. That is, health status has improved in poor countries at a faster rate than in 
rich countries (albeit from a lower base), despite the fact that incomes have grown more slowly 
in poor countries than in rich. 
 
In view of the difficulties and limitations of cross-country comparisons, we summarize the 
evolution of incomes and health status in two countries—China and India—since 1960. (This 
exercise follows Deaton 2006; Drèze and Sen 2002). Figure 4 suggests that both of these 
countries have improved their health status and per capita incomes over the last 40 years but that 
their experiences have differed.  
 
Figure 4. Income Growth and Infant Mortality Rate Reductions 
in China and India, 1960–2000 
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Source: World Bank data, as used by Deaton 2006; see his figure 8. 
Note: Each line shows the annualized proportional change for a variable over the preceding five years. IMR is infant 
mortality rate. 
                                                 
3. The reversal of the converging trend in life expectancy in the last 15 years is likely due to the collapse of the 
former Soviet Union, which exhibits high adult mortality, and to the explosion of HIV/AIDS in Sub-Saharan Africa 
in the 1990s. HIV/AIDS, while it has implications for children and potentially for their incomes later in life—
through its impact on schooling—has a more pronounced impact on adult life expectancy than on infant and child 
mortality.  
  10In China the annualized growth rate of GDP is negatively correlated with the annualized rate of 
reduction of the infant mortality rate (correlation coefficient −0.45, t statistic), while in India the 
correlation is positive (correlation coefficient 0.77, t statistic). As Deaton (2006) notes, in China 
the largest gains in health preceded the takeoff in economic growth.  
 
The data from India are perhaps more ambiguous: during that country’s period of relatively slow 
economic growth from 1965 to 1985, the correlation between changes in income and health was 
tight, but in more recent years, as economic growth has taken off, the rate of improvement in the 
infant mortality rate has fallen off. 
 
Interpreting Correlations between Health and Income: Data and Estimation Issues  
 
Research on the links between health and growth are fraught with measurement problems from 
the selection of variables and the validity of those measures to the econometric problems 
common where there is reverse causality. Creative solutions to these challenges have met with 
mixed results, but from a policy perspective the bottom line is a tenuous link between health and 
growth at the macroeconomic level. This section reviews the measurement issues, the analytic 
constraints, and alternative options for capturing the correlations between health and income. 
 
Limitations of Aggregate Measures of Health and Income  
 
Although relationships between aggregate measures of health and income can be informative, 
they have some limitations because both indicators are summary statistics of complex, 
multidimensional assessments of human activity and well-being.  
 
Measuring “health” is tricky, and no measure aptly captures morbidity and mortality (Schultz 
2005). In particular, the use of life expectancy or infant and child mortality rates as measures of 
health status is not without ambiguity, for both conceptual and practical reasons. First, these 
indicators attempt to measure aspects of health that might be related to productivity, including 
the extent to which individuals experience, or are at risk of, bad health, encompassing both 
morbidity and premature death. For example, in using life expectancy in cross-country analysis, 
we place too much weight on infant mortality, while that measure itself is an imputed variable in 
most contexts. Mortality is also a one-time event and remains rare even in high mortality 
settings. Despite the heavy reliance on mortality statistics to measure health, for all these reasons 
mortality is a suboptimal measure of “health.” 
 
Second, at a practical level, accurate measures of life expectancy require good vital registration 
data, particularly on deaths. In many developing countries, these data simply do not exist, and 
estimates of life expectancy are based on child mortality rates, using standard life tables to 
impute infant mortality levels (adjusting for guesses about mortality risks in the population 
where necessary). While the cross-country pattern of life expectancy levels is likely to be 
reasonably accurate, data on changes in life expectancy may well embody large errors, due to the 
variety of (unmeasured) causes of such changes. 
 
Third, interventions that affect morbidity but not mortality may well have important effects on 
productivity that will not be attributed to changes in health status if the latter are measured by 
  11life expectancy or infant and child mortality rates. A primary example of such an intervention is 
the control of the vivax strain of malaria, which causes relatively few deaths but high morbidity 
rates, compared with the more lethal falciparum strain. Controlling vivax malaria could 
significantly boost productivity, both directly as adults suffer fewer and less severe attacks and 
indirectly through increases in the return to, and hence the level of, schooling for children 
(Bleakley 2006b). Alternative measures of morbidity (illness) such as self-reported health status 
or activities of daily living are not only rarely available but tend to be less reliable than 
objectively collected data, and they are hard to compare across countries.   
 
Econometric Approaches  
 
Interpreting the observed correlations between country-level health status and income is 
challenging. First, it is very likely that higher incomes help to improve health status. Second, 
there may be other factors that affect both income and health in a country (Deaton 2006); for 
example, these might include the country’s climate and its disease environment. For both of 
these reasons, a correlation between income and health might be observed even if there is no 
direct causal relationship from health to income.  
 
These identification problems are at the root of the lively debate among economists and public 
health researchers and are well recognized. For example, Bleakley (2007: 73, 74) notes, “Simple 
correlations of public health and economic outcomes are unlikely to measure the causal effect [of 
health on income] since public health is endogenous. Indeed, it is likely a normal good.” 
Similarly, in a paper focusing on the impact of malaria, Malaney, Spielman, and Sachs (2004: 
143) acknowledge concerns over endogeneity and omitted variables: “The causal effect of 
malaria on poverty cannot readily be isolated from the effect of poverty on malaria. A second 
econometric problem lies in the effect of such confounding factors as climate that may drive both 
poverty and malaria.” 
 
Researchers have used various procedures to try to overcome these and other estimation 
problems. Some studies focus on the relationships between measures of population health (such 
as life expectancy) and national income (such as GDP) and use econometric techniques to correct 
for endogeneity and omitted-variable biases; we refer to these as macro approaches in the 
discussion that follows. At the other extreme, micro approaches examine the link for individuals 
between health improvements and incomes, with the goal of minimizing identification problems 
by careful choice of setting. A third strand of the literature combines the macro and micro 
approaches within a growth-accounting framework, scaling up micro-level measures of the 
effects of individual health improvements on incomes to yield macro-level estimates of the 
impact of changes in population health on national income. The following subsections briefly 
review the findings of studies using the macro and growth-accounting techniques. Subsequently, 
we explore the more micro approaches. 
 
Findings of Macroeconomic Studies  
 
If we look at a wide enough range of countries, we find that people in richer countries are on 
average healthier: they live longer and fall ill less often. A cross-country regression quantifies 
this correlation. One of the first contributions to this literature is the work of Pritchett and 
  12Summers (1996), who conclude that “wealthier was healthier”—that is, the causality ran from 
income to health.  
 
Subsequent work focused on the link between health and changes in income: healthier countries 
might be richer, but do they grow more quickly? Gallup and Sachs (2001) address this question 
and find a strong correlation between the level of population health and income growth. Of 
course, there are obvious endogeneity and omitted-variable concerns with this kind of exercise, 
but it offers the tantalizing prospect that a country can raise its income by improving its health. 
 
A range of papers subsequently refined and extended the Gallup and Sachs methodology. Bloom, 
Canning, and Sevilla (2004) report the results of 13 studies that all employ cross-country 
regressions and all show large effects of health on growth. To try to correct for possible third 
factors that affect both the level of health and the growth of income, Bloom, Canning, and 
Sevilla (2004) assess the correlation between changes in health status and changes in income 
across countries; they find similar results. 
 
The problem of endogeneity affects virtually all of the cross-country studies in this genre, 
because differences in the levels and growth rates of income can plausibly affect the levels and 
changes in health status. The methodological response is to use a proxy indicator for health status 
(or for changes therein), which the researcher believes does not directly affect the level or growth 
of income. Any observed correlation between such an “instrumental variable” and income is then 
evidence of a causal link from health to income.
4 
 
Gallup and Sachs (2001) use geography as an instrumental variable for health status. The basic 
epidemiology and biology of infectious diseases mean that at any given level of income these 
diseases are likely to be more prevalent in tropical regions. An impact of geography (distance 
from the equator) on incomes might then constitute evidence of an impact of health on incomes. 
This approach has been questioned in a series of papers (Acemoglu, Johnson, and Robinson 
2002; Easterly and Levine 2003; Rodrik, Subramanian, and Trebbi 2002) that challenge the 
assumption made by Gallup and Sachs that geography does not affect growth either directly or 
through its impact on a third factor that is itself important for growth. In particular, these critics 
illustrate that, once the effect of geography on a country’s choice of institutions is accounted for, 
geography has little independent impact on incomes. Broadly speaking, tropical equatorial 
countries have tended to adopt institutions that are less conducive to economic growth than have 
other countries, and it is the choice of institutions that induces a correlation between health and 
income. The stark implication of their findings is that improving health status (by, say, 
expanding the use of bed nets to reduce the incidence of malaria) would have little impact on 
overall growth and that institutional reform is what is needed to increase income.  
                                                 
4. Bloom, Canning, and Sevilla (2004) use lagged values of health-related inputs and economic output (and their 
lagged growth rates) as instruments. However, Weil (2005) questions the validity of this strategy and claims that 
“the identifying assumption required … is not explicitly stated or defended.” Mankiw (1995: 303–04) goes as far as 
to suggest that “cross-country data can never establish, for instance, the direction of causality between investment 
[or health] and growth.” He notes the implausibility of lagged variables being good instruments, highlights the issue 
of multicollinearity—“those countries that do things right do most things right, and those countries that do things 
wrong do most things wrong”—and illustrates how lack of independence and measurement errors (both of which are 
acute in cross-country regressions) can bias results. 
  13Sachs (2003) admits the possibility that geography affects institutional quality, but takes issue 
with the finding that this is the only effect that geography has. To this end, he conducts a series 
of cross-country regressions aimed at distinguishing the effect of malaria prevalence—which is 
highly correlated with geography—from that of institutional quality. Instead of using a simple 
measure of geography (distance from the equator) as a proxy for health outcomes, which are 
arguably correlated with income, he constructs two instruments: one for malaria risk, which he 
calls “malaria ecology” and which is based on climatological conditions and vector prevalence, 
and one for institutional quality, which is based on settler mortality and the share of a country’s 
population living in temperate zones. In all his specifications he finds that both institutional 
quality  and malaria risk are statistically significant determinants of income. But even this 
approach does not escape methodological criticism. In particular, the measured impact of malaria 
ecology on growth is unbiased only if we believe that malaria ecology does not affect 
institutional quality. 
 
Aside from the econometric issues that arise when conducting cross-country regressions, one 
should not rely too heavily on results that selectively exclude some countries. Bloom and 
Canning (2003b) illustrate this point. They analyze how the demographic changes in East Asia 
that were brought about by health improvements led to increased savings and growth. They then 
reflect on the experience of Latin America, which had “broadly similar demographic and health 
conditions,” and note, “East Asia’s economy grew explosively, while economic growth in Latin 
America was stagnant. Latin America’s policy environment—with poor labor market policies, a 
lack of openness to world markets, and an inadequate education system—was quite different 
from East Asia’s and did not offer the same favorable conditions.” While it may be that the 
interaction of good policies with good health is what matters, the comparison between East Asia 
and Latin America suggests that it is, to first order, simply good policy that matters. 
 
Several recent papers have attempted to identify the impact of health on income and growth by 
modeling innovations in the health environment that can plausibly be taken as exogenous. For 
example, Acemoglu and Robinson (2008) investigate whether advances in the health sciences 
have affected national income. They analyze the considerable technical progress in drug 
therapies, vaccines, insecticides, and the dissemination of scientific knowledge through 
international organizations that occurred in the twentieth century and find that these advances did 
not cause a rise in per capita income. For their study, the authors construct a measure of how 
much a country could expect to gain from these technological and institutional innovations—
countries with a high incidence of now curable or avoidable diseases would be predicted to have 
greater gains in terms of reduced mortality—and use this measure as an instrumental variable for 
actual changes in population health. The idea is that the instrument is correlated with actual 
improvements in health, but not directly with changes in income. They find that the advances in 
medicine significantly raised the growth rate of population and that income (as measured by 
GDP) also increased. Since the increase in income did not match the increase in population, real 
per capita income fell, despite the health improvements. This effect is essentially a general 
equilibrium phenomenon: labor supply rose, while other factors (land, capital) did not adjust, 
thereby reducing per capita output.  
 
Their result mirrors that obtained by Young (2005), who uses micro data to calibrate a 
neoclassical growth model with fertility effects, in order to estimate the impact of the HIV/AIDS 
  14epidemic in South Africa. Young finds that, because of the negative effect of the epidemic on 
population, capital-labor ratios increase enough to offset any plausible reduction in the rate of 
intergenerational human capital transmission associated with parental deaths. 
 
Commenting on a paper by Acemoglu and Johnson (2006; see also Spence and Lewis, 
forthcoming), Bleakley (2006a) notes that these authors find no impact of health changes on 
aggregate GDP. He emphasizes that labor market conditions, in particular the extent of 
unemployment and underemployment, are crucial in determining the impact of health 
improvements on measured GDP. Suggesting that a model assuming that capital is fixed is 
inappropriate, Bleakley notes that in reality the capital stock should have responded over the 40 
years covered by these authors’ analysis and that land productivity too is likely to have improved 
over the period (due to increased urbanization and the green revolution in agriculture). 
 
Using Growth Accounting to Assess the Impact of Health on Economic Returns  
 
Another group of studies attempts to overcome the shortcomings of the macroeconomic evidence 
by adding microeconomic elements. Their use of more refined techniques and reliance on 
measures that better capture the economic effects of health and nutrition investments arguably 
provide a firmer foundation than the macro studies for drawing conclusions about the link 
between health and growth. 
 
Shastry and Weil (2003) and Weil (2005) use a different methodology to estimate the share of 
cross-country variation in income that can be associated with differences in health status. 
Combining microeconomic estimates of the impact of health on productivity with a 
macroeconomic accounting model, they decompose aggregate country output into a (residual) 
productivity term plus the return to certain factors, including physical capital, educational human 
capital, and health human capital. Measures of output, physical capital, and educational capital 
(proxied by years of schooling) are readily available for some countries, although admittedly a 
subset, particularly for education; the challenge is to construct a measure of health that is 
relevant to productivity. 
 
Weil’s (2005) approach to accounting for the effect of health on economic performance is to 
estimate the returns (in terms of higher wages) to a number of health indicators, including adult 
height, adult survival rate, and age of menarche, using instruments for differences in health 
inputs, birth weight differences between twins (see, for example, Behrman and Rosenzweig 
2004), and historical data on caloric intake (see Fogel 1997). He finds that a 10 percent increase 
in the adult survival rate would lead to an increase in labor input per worker of 6.7 percent and in 
GDP per worker of about 4.4 percent. Notably, this estimate of the increase in GDP per worker is 
much smaller than other such estimates in the literature.
5 Weil calculates that about 9.9 percent 
of the variance of log GDP per worker is attributable to health and nutrition gaps between 
countries. He concludes, “My estimates do not match the characterization of ill health as a major 
stumbling block to economic development, as described in the WHO [World Health 
Organization] report on macroeconomics and health.”  
                                                 
5. Indeed it lies below the lower bound of the 95 percent confidence interval for the same measure as estimated by 
Bloom and Canning (2005) using a cross-country regression with lagged variables as instruments. 
  15When general equilibrium effects associated with fertility and population changes are 
incorporated into Weil’s analysis—which, as Acemoglu and Robinson (in Spence and Lewis, 
forthcoming) point out, implicitly assumes a fixed population size—the estimated impact of 
health on per capita income may be somewhat smaller. However, the aggregation methodology 
does not allow for certain behavioral responses to improved health, such as changes in savings 
rates or educational choices, which could possibly increase incomes in the long term. In a more 
recent paper, Ashraf, Lester, and Weil (2007) incorporate these additional channels by which 
health changes might affect growth, but they still find only modest income gains. 
 
The conclusions from these combined micro-macro studies suggest some limitations. As 
discussed below regarding microeconomic studies (for example, Bleakley in Spence and Lewis, 
forthcoming), health improvements can improve economic performance but are unlikely to 
explain why some countries lag far behind others in material well-being. Moreover, because the 
most significant health improvements occur early in a person’s life, the associated income effects 
take a long time to come to fruition. 
 
 
The Links between Individual Health and Productivity: Microeconomic Evidence on 
Health and Growth  
 
An alternative approach to studying links between health and income is to examine individual 
and household investments and their effects on household income. The advantage of this 
approach, given data of sufficient quality, is that we might have more confidence in attributing 
certain impacts to particular health or other variables.  
 
The disadvantages of a microeconomic approach are that the results may not be easily applicable 
to other circumstances and that what may be true at the micro level may not apply for the 
population at large, because of external or general equilibrium effects. For example, if the labor 
market rewards individuals solely according to their health rank (healthier people get more job 
offers), then improvements in one person’s health will translate into increases in his or her 
income, matched by reductions in the income of others, and there will be no impact on aggregate 
income. More generally, as in Acemoglu and Robinson (2008), if workers use other factors of 
production that are in relatively fixed supply, such as land and capital, then health improvements 
that increase the supply of labor could conceivably reduce average output per worker. Micro-
level studies cannot pick up such effects.  
 
Despite these shortcomings, micro approaches provide important insights into the potential 
impact of health on economic well-being. Below we focus on two broad sources of health-related 
variation across individuals and see how these translate into differences in economic 
productivity. The first source of differences among individuals is in the basic inputs to a healthy 
and productive life; we report on the economic implications of these differences and on the 
results of interventions to improve nutrition and caloric intake, on the one hand, and to enhance 
early childhood development, on the other. The second source of differences is in the incidence 
of illnesses and the access to and use of medical treatments; we report the findings of select 
studies on the negative impacts of HIV and malaria on productivity and the economic impacts of 
treatments such as deworming tablets and antiretroviral therapy. 
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Mounting evidence from economics, psychology, and neuroscience indicates that early 
investments in young children profoundly affect their long-term physical and mental health, 
earnings, and well-being. Early experience shapes brain architecture (Knudsen and others 2006), 
and early childhood development has a long reach that affects physical and mental health and 
well-being later in life (Drukker and Tassenaar 1997; Fogel 1994; Mustard 2006). Knudsen 
(2004) has shown that there are sensitive periods for neurological development early in life that 
affect long-term memory. Thus the critical period for intervention is in the preschool years. 
Recent work has produced considerable evidence on the issue.  
 
Victora and others (2008) summarize the results and long-term implications of maternal 
undernutrition from five developing-country cohort studies and review the literature on the same 
topic. They find that undernutrition can cause structural damage to the brain and that maternal 
and child undernutrition result in shorter adults, less schooling, lower productivity, and lower 
birth weights among their offspring. There is also a link with adult cancer, lung disease, and 
mental illness, all of which compromise productivity and earnings.  
 
Thomas and Frankenberg (2002) provide a useful review of microeconomic studies of the impact 
of nutrition on economic outcomes at the individual level. They summarize their findings as 
indicating that “while the establishment of this link [from health to income] is not 
straightforward, the weight of evidence points to nutrition, and possible other dimensions of 
health, as significant determinants of economic productivity.” Walker and others (2007), in a 
meta-study of risk factors for young children, note that stunted children consistently show 
cognitive and educational deficits, although the size of the deficit varies across settings. They 
argue for intervention to prevent stunting, inadequate cognitive stimulation, iodine deficiency, 
and iron deficiency anemia.  
 
Heckman (2007) points out the importance of noncognitive skills in preparing children for 
school, adulthood, and the workplace, and his research suggests that both the cognitive and 
social-emotional abilities of individuals as children explain many features of their later economic 
and social performance. Gaps in cognitive ability are established early, and in the United States 
they explain much of the differential in individuals’ educational performance across income 
levels (Cunha and others 2006). 
 
Grantham-McGregor and others (2007) summarize the scientific and behavioral evidence from 
developing countries and point to poverty, malnutrition, poor health, and unstimulating home 
environments as compromising the cognitive, motor, and social-emotional development of 
children. Their meta-study finds that both poverty and childhood stunting (due to persistent 
undernutrition) correlate with poor school performance, lower income in adulthood, higher 
fertility, and inadequate care of their own offspring.  
 
Longitudinal studies show the relationship between early childhood development and language, 
intelligence, and criminality. Black and others (2008) show how low birth weights significantly 
affect longer-run outcomes such as adult height, intelligence quotient, earnings, and education. 
Verbal exposure by reading and talking has significant effects on children’s verbal skills and 
  17language at later stages of development (Mustard 2006: 33). Many studies (cited in Mustard 
2006: 37) have shown that children with poor verbal skill development during their first three 
years of life do poorly in language and literacy in school.  
 
Both stunting and poverty are associated with declines in years of schooling. In Brazil, low-
income, stunted children receive more than four fewer years of schooling on average and, once 
they become adults, earn an estimated 30 percent less income than the average worker 
(Grantham-McGregor and others 2007).
6 Thomas and Strauss (1997) show almost a 20 percent 
reduction in returns to schooling among self-employed males in Brazil when height is added to 
the wage function.  
 
Studies of adult literacy in the United States under the U.S. Department of Education National 
Education Assessment Program have shown that children with the lowest physical and mental 
health also perform at the bottom of the distribution in standardized tests. Figure 5, from 
Grantham-McGregor and others (2007), shows the cognitive deficits resulting from being in the 
lowest wealth quintile in the first three years of life. On the basis of income, the standard 
deviations in cognitive and schooling deficits of children (z scores) in the poorest 20 percent of 
households are significant. The five countries featured represent three continents and both low- 
and middle-income groups, suggesting that culture and location are less important than biology 
in determining these deficits. 
 
Figure 5. Cognitive or Schooling Deficits Associated with Moderate Stunting in Children 
Less Than Three Years from Six Longitudinal Studies 


























       Source: Grantham-McGregor and others 2007. 
                                                 
6. Stunted children with limited cognitive skills are more likely to drop out and to learn less when they do stay in 
school (Grantham-McGregor and others 2007). 
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and young children, has achieved significantly better performance on literacy assessments, 
scoring two standard deviations higher, than any other Latin American country (Carnoy and 
Marshall 2005, as cited in Mustard 2006: 39).  
 
Fogel (2002) and Alderman, Behrman, and Hoddinott (2003) show the importance of specific 
nutrition interventions in bolstering cognitive development, physical stature and strength, earlier 
school enrollment and more regular school attendance, greater schooling and learning, increased 
adult productivity, and healthier offspring.  
 
A recent 35-year longitudinal study of the long-term impacts of nutrition intervention during 
early childhood provides striking results (Behrman in Spence and Lewis, forthcoming; Melgar 
and others 2008). Two nutrition supplements were randomly assigned to low-income children in 
rural Guatemala; children who consumed the protein-rich supplement achieved dramatically 
better educational performance and labor force earnings. Women who received the protein-rich 
supplement during their first three years of life attained 1.17 more years of schooling, their 
infants’ birth weight was 179 grams heavier, and their children were a third taller than those of 
women who consumed the calorie-based supplement as children. Men who consumed the high-
protein supplement in the first two years of their childhood earned an average wage 46 percent 
above that of men who consumed the calorie-based supplement.  
 
Thus the evidence on the value of interventions in the preschool years is striking. Indeed, recent 
evidence (see Figures 6 and 7) suggests that the economic rate of return to preschool attendance 
dwarfs the returns to university or job training (Carneiro and Heckman 2003) and that the lack of 
attention to early childhood development has high long-run costs (Heckman 2007).  
 
Figure 6. Returns to Different Levels of Education Based on Family Background 































             Source: Adapted from Cunha and others 2006. 
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                   Source: Wößmann and Schütz 2006. 
 
Investments in individual children before the age of three produce more significant impacts than 
any other social or health investments and at a lower marginal cost (Carneiro and Heckman 
2003). Only investments in public health improvements may be more important, but these tend to 
be complements to, rather than substitutes for, interventions targeted to young children.  
 
To sum up, interventions affecting early childhood development produce long-term benefits for 
human capital and productivity. The microeconomic studies reviewed above suggest that 
prenatal care, food supplements for malnourished children, micronutrients, and preschool for 
disadvantaged children, among other such investments, help to raise the potential for long-term 
academic and workplace success and lifelong well-being. These results are among the most 
robust in terms of the direct impacts on individuals and long-term implications for enhanced 
health status, productivity, and income. Perhaps even more important is the potential impact on 
the next generation. Indeed, these findings suggest that the cycle of poverty, morbidity, and early 
mortality can be broken by interventions in early childhood. 
 
Unfortunately, early childhood investments have not received enough attention or resources. 
Developed and developing countries alike now have a major opportunity to enhance human 
capital by turning their attention to such investments. 
 
Impact of Illness on Income  
 
Investments in young children and better nutrition for malnourished children are likely to make 
people healthier and less likely to fall ill. But what happens to productivity when people do fall 
ill? A broad literature addresses this issue, using the so-called cost-of-illness approach to 
measure the impact of health on income. Some studies focus on the immediate impacts of illness, 
including reduced labor supply and the lower productivity of sick people while on the job, and 
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disengagement from economic activities. 
 
Two studies by Bleakley (in Spence and Lewis, forthcoming) examine the effects of disease-
eradication campaigns on health and economic outcomes; his results suggest that improving 
health could be important for growth on the margin but is unlikely to be a panacea. In his 2007 
study of the impact of hookworm eradication efforts under the Rockefeller Sanitary Commission 
in the American South in the early twentieth century, Bleakley measures the infection rates that 
prevailed before the intervention; on average, 40 percent of school-age children were infected. 
Like Acemoglu and Johnson (in Spence and Lewis, forthcoming), he uses data on infection rates 
by location, which reflect the geographic variation in potential benefits from hookworm 
eradication, to identify the impact of changes in the health environment on economic outcomes.  
 
Bleakley finds that areas with higher preexisting infection rates saw greater increases in school 
enrollment, attendance, and literacy after the intervention. For example, he finds that school 
attendance before 1910 was negatively correlated with 1913 infection rates, but that by 1920 the 
1913 infection rates did not predict attendance. That is, those areas that had more to gain from 
hookworm eradication saw their school enrollment rates increase more. Bleakley finds similar 
results for literacy. Other changes in the economic environment could have led to similar trends 
over this period, but he argues that, if so, these influences would have affected adults in different 
areas in similar ways. However, he finds no similar pattern among adults across the affected 
areas who, by the nature of the disease, had virtually no preexisting infection. 
 
Bleakley (2006b) undertakes a similar exercise focusing on the malaria eradication campaigns in 
the United States circa 1920 and in Brazil, Colombia, and Mexico circa 1955. Preexisting 
prevalence rates across regions, combined with a paced eradication campaign across the U.S. 
South, which provide exogenous variation, permit him to identify the impact of childhood 
exposure to malaria on future adult literacy and incomes. He finds that, among individuals born 
well before the relevant eradication campaign, those born in more malarial regions had lower 
wages and lower literacy rates later in life, while among individuals born well after the 
campaigns, malaria prevalence before the eradication campaign had little effect on future wages 
and literacy. He concludes, “Persistent childhood malaria infection reduces adult income by 40 
to 60 percent.”  
 
Bleakley is able to differentiate the impact of morbidity from that of mortality on future income. 
He finds that eradication of vivax malaria (which causes high morbidity, but relatively few 
deaths) leads to significant increases in human capital formation and future income, but that 
eradication of falciparum malaria (which is often fatal) produces no such gains. To explain this 
result, he argues that, although reductions in mortality rates increase the marginal benefit of 
human capital acquisition (because people who survive have more years in which to earn a return 
on human capital investments), this might have little impact on the level of investment if 
marginal costs are rising steeply. By contrast, a reduction in morbidity makes it easier to attend 
school and to learn while there, thereby flattening the marginal cost curve and leading to 
significant increases in human capital acquisition.  
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for about 10–16 percent of the income gap between the United States and Latin America. This 
suggests that eradicating malaria could modestly narrow the income gap by inducing higher 
growth in Latin America. He concludes, “While reducing malaria could bring substantial income 
gains to some countries, the estimated effect is approximately an order of magnitude too small to 
be useful in explaining the global income distribution” (Bleakley 2006b: 26). 
 
Several other studies of the effects of malaria eradication programs find that the control of 
disease vector environments has a profound effect on health status and on education and 
productivity. Cutler and others (2007) examine the impact of a malaria eradication program 
across Indian states during the 1950s and find that the program increased literacy and primary 
school completion rates by 10 percentage points, accounting for about half the observed gains in 
these measures over the period spanning the intervention in malarial regions. Barecca (2007), 
Hong (2007), and Lucas (2005) all find significant effects of either exposure to malaria or its 
eradication on a variety of economic outcomes such as schooling, literacy, labor force 
participation, and wealth. These findings call to mind the broad-ranging positive results of the 
West African Onchocerciasis Control Program, discussed above. 
 
The recent expansion in the availability of antiretroviral drugs in Sub-Saharan Africa has enabled 
researchers to examine the impact of HIV/AIDS treatment on labor market outcomes. The effects 
on labor supply and income seem to be considerable. In a study in western Kenya, Thirumurthy, 
Graff Zivin, and Goldstein (2005) find that, within six months of starting treatment, a patient is 
20 percent more likely to participate in the labor force and has a 35 percent increase in weekly 
hours worked. Larson and others (2008) study a similar expansion of antiretroviral treatment 
(ART) in Kericho, a tea-growing region of western Kenya. They find that in the nine months 
before starting ART, HIV-positive individuals worked significantly fewer days plucking tea each 
month than their comparators without HIV, but that, after starting ART, the individuals 
undergoing treatment quickly increased the number of days they spent on this work (to 6.8, 11.8, 
and 14.3 days a month at one, six, and 12 full months on ART, respectively), while the labor 
supply of their comparators remained constant at 17–18 days a month. Also, during the first six 
months on ART, the individuals on treatment earned on average 25 percent less than their 
comparators, but during the next six months of therapy they raised their earnings to 89 percent of 
those of their comparators.  
 
Health care can work to improve children’s school attendance as well as adults’ labor supply. 
Miguel and Kremer (2004) provide something of a benchmark analysis of the link between 
health care and schooling by examining the impact of randomly assigned deworming treatment 
across schools in western Kenya. They find that the intervention reduced student absenteeism by 
a quarter, with the larger gains among the youngest students and among girls compared with 
boys. Despite the impressive gains in school attendance, however, their study found no effect on 
educational outcomes as measured by test scores. This may be because school attendance was 
not enough to ensure good academic performance: complementary inputs such as teachers and 
facilities may have been sufficiently poor, or sufficiently overstretched, that children’s additional 
days at school had little impact on learning.
7  
                                                 
7. Miguel and Kremer (2004) suggest that the classroom overcrowding that resulted from lower infection rates could 
have offset any positive effect from lower absenteeism.  
  22Another route by which health affects schooling is orphanhood. This has received a great deal of 
attention in the literature on the economic effects of AIDS. If orphans receive less education, 
then the intergenerational transmission of human capital can be interrupted, with important, and 
potentially disastrous, long-term effects (Bell, Devarajan, and Gersbach 2003). Case, Paxson, 
and Ableidinger (2002) use demographic and health surveys across 10 Sub-Saharan countries to 
examine the impact of orphanhood and find that orphans are significantly less likely than other 
children to be enrolled in school. In this study, however, the repeated cross-sectional nature of 
the data means that the interpretation of the results is not without ambiguity. Gertler, Levine, and 
Ames (2004) use panel data from Indonesia and find that a parental death doubles the probability 
that a child will drop out of school the same year. Neither of these two studies finds a gender 
effect, either at the parent or child level. Other studies
 find little impact of parental death on 
schooling, possibly because members of extended families take on the parenting function 
(Ainsworth, Beegle, and Koda 2002; Kamali and others 1996; Lloyd and Blanc 1996).
8 
 
Consistent with this view, Fortson (2006: 26) reports that children in areas in southern Africa 
with high HIV prevalence are “less likely to attend school, [are] less likely to complete primary 
school, and progress more slowly through school.” Fortson shows that more than half of this 
impact on schooling can be attributed to the expectation of a shorter life of the parent and not to 
orphanhood itself; all children do badly when adults expect to die sooner. Reductions in adult 
mortality might lead to greater investment in children’s education, because of higher demand 
either by parents or by children themselves, who expect to reap the future returns for longer. 
 
Another important dimension of poor health is the economic impact it has on other people. 
Thirumurthy, Graff Zivin, and Goldstein (2005), studying the impact of HIV/AIDS treatment in 
Kenya, find that the labor supply of other household members changes: young boys and women 
in the household work considerably less after the patient in their family starts treatment, although 
girls and men in the household do not change their labor supply. The authors highlight the 
important potential implications for schooling outcomes. Beegle, De Weerdt, and Dercoon 
(2006) study the impact of mortality from AIDS on the economic well-being of surviving 
household members, in both the short and long term, in a 13-year cohort of individuals in 
Tanzania. The authors find that households who have experienced an adult death due to AIDS 
see a reduction in their consumption of 7 percent after five years, while households not so 
affected see an increase in their consumption of 12 percent over the same period. Thus, vis-à-vis 
the average household, households who experience an adult death due to AIDS suffer a 19 
percent fall in consumption after five years. There is some evidence that such losses are 
persistent, although they are estimated imprecisely, and the possibility that they are reversed in 
the long term cannot be rejected. An interesting finding is that losing a female adult to AIDS 





                                                 
8. Evans and Miguel (2003), as discussed in Miguel (2005), use data from the randomized deworming project in 
western Kenya to address some of the identification issues that trouble cross-sectional and panel data studies. Their 
results on the impact of parental death on schooling mirror those of Case, Paxson, and Ableidinger (2002) and 
Gertler, Levine, and Ames (2004): parental death seems to reduce schooling, and there is little difference by gender. 
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The above review of the literature suggests that the macro link from health to growth is still not 
beyond dispute, although our interpretation is that the link, if it exists, is relatively small. 
However, individuals and households can improve productivity and boost their incomes with 
specific health-related investments. 
 
What this means for policy choices is not immediately clear. Improving life expectancy by a year 
might increase a country’s income by some amount, but how such a health improvement is to be 
achieved is the subject of a whole separate literature. However, we need to examine whether we 
care about health only for its own sake or also for its potential role in improving incomes.  
 
Experience shows that it will not be that easy to spend our way to better health and thence, if 
there is a causal link, to higher growth: just as growth-inducing policy interventions are elusive, 
so too health-improving strategies can be difficult to identify and politically unpopular.
9 All too 
often the link from spending on health care to health outcomes is weak (Filmer, Hammer, and 
Pritchett 2000). The question is why that is the case and what interventions and policies can 
remedy the situation. 
 
Market Failures and the Financing and Delivery of Health Care  
 
As well as investing in public goods that improve health and hygiene, all governments take an 
active role in financing and providing health care, which has the attributes of a private good, 
given the significant failures in private markets for both health care and insurance. Economists 
have long understood the limitations of unfettered private markets in delivering health care. First, 
an agency problem can exist between the provider and the patient: the patient, being at an 
informational disadvantage, might not know the cause of illness or what health intervention, if 
any, is appropriate, and she is at the mercy of the provider. Of course, similar problems exist in 
many service markets, from auto repair to accounting services, many of which appear to operate 
reasonably well. 
 
The second feature of medical care markets that can restrict their efficiency is individuals’ need 
for insurance against the possibility of random catastrophic events. Such events can expose 
individuals to significant risks, but adverse selection might limit the extent to which private 
markets can spread those risks. Governments sometimes respond by financing or delivering 
medical care themselves (as in the U.K. National Health Service), in order to maintain coverage 
of a broad pool of individuals. This desire to provide a safety net explains the significant 
presence of public spending on health in most developing countries and, especially, in countries 
in transition from communism, where governments continue to dominate health care delivery.  
 
                                                 
9. Indeed, while the technical and scientific knowledge exists to solve many health problems, the fact that these 
solutions are often not widely adopted suggests that they are not simple to implement (World Bank 2005). For 
example, oral rehydration therapy (ORT) is a simple and cheap way to reduce diarrhea, which kills more than 4 
million children a year. But ORT fails to reach needy families in some developing and transition countries for the 
same reasons that most redistributive policies are not fully effective: political tradeoffs, vested interests, corruption, 
and a general lack of resources. 
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care. Examples include the U.S. insurance programs for the elderly (Medicare) and the poor 
(Medicaid) and the Australian, French, and German health care systems. In much of the 
developing world, universal health care translates into government financing and provision along 
with parallel out-of-pocket costs and insurance purchases from the private health sector, 
mandatory wage taxes, or general revenue that underwrites health care costs. Transition 
countries, with their history of generous government financing and provision, now combine 
public provision and finance with some private sector activity and informal, under-the-table 
payments to public providers.  
 
Relatively open-ended public insurance coverage, in conjunction with strong profit motives in 
the private sector, can often lead to inefficient levels of care, such as overprescription of drugs 
and unnecessary procedures. Not facing the (marginal) cost of their decisions regarding the use 
of services, physicians order and patients opt for excess testing, treatment, and other benefits. 
Even if there is no agency problem between provider and patient, insurance leads to 
overconsumption. To control costs, these moral hazard effects have led to the introduction of 
provider payment arrangements that reward performance and discourage overspending (for 
example, prospective payments systems), rationing of care, and other cost-control measures.  
 
Physician agency, adverse selection, and moral hazard together suggest that health care services 
will be provided excessively to people with insurance and deficiently to people without. In 
practice, however, the failures of the medical care market are more nuanced. While spending 
might be excessive in some countries, the actual delivery of useful services does not always 
follow suit: far from spending and getting too much, society spends too much and gets too little. 
Similarly, the theory of adverse selection implies that the bad (risks) will drive out the good 
(risks), but policy makers usually express exactly the opposite concern: that people with high 
risks will not be able to afford insurance. Publicly financed insurance is then likely to appear 
expensive, precisely because it covers relatively expensive, high risk individuals. 
 
Cross-Country Evidence on Health Care Spending and Health in Developing and Transition 
Countries  
 
Cross-country evidence on the link between health care spending and health status is not 
encouraging. Both market and government failures combine to complicate the design of health 
policy, in general, and the financing and delivery of health care, in particular. Indeed, 
considerable debate continues over what effect, if any, public spending on health care has on 
health in developing and transition countries. At first, this ambiguity seems surprising: surely 
spending on widgets should produce widgets? 
 
The reasons why public spending on health care might not improve health, as set out by Filmer, 
Hammer, and Pritchett (2000), are economically straightforward. First, if there is a functioning 
private market for health care, public spending may simply replace private activities, rather than 
adding to the aggregate supply of health care. Second, public purchase of health care services 
does not necessarily assure their delivery to patients: doctors who are paid but do not show up to 
work, drugs that are procured but are siphoned off, and diagnostic equipment that lies idle for 
lack of maintenance or complementary inputs, such as electricity or skilled labor, all contribute 
  25to health spending, but not to health. Third, the technical efficacy of some health care spending 
(on garlic as a cure for AIDS, for example) is very low or even zero, so that even if some 
publicly financed services are delivered to patients, they might have little effect. 
 
One way to examine the impact of public spending on health is to employ cross-country 
regression techniques, as in the health-income literature reviewed above. In this case, though, we 
can be somewhat more confident about the use of cross-country comparisons, because problems 
of endogeneity seem to be less severe: it is unlikely that better population health would, in itself, 
lead to greater public spending on health.  
 
Filmer and Pritchett (1999) regress under-five mortality on a variety of variables, including 
public health spending, and find that virtually all the cross-country variation is attributable to 
average per capita income, its distribution, female education, ethnolinguistic diversity, and 
religious and regional dummy variables. That is, health spending is more or less uncorrelated 
with health outcomes: independent variation in public health spending explains a paltry one-
seventh of 1 percent of the variation in child mortality.  
 
Wagstaff and Claeson (2004) examine how these results are affected by good governance. They 
find that health spending does reduce under-five mortality as long as the quality of governance, 
as measured by the CPIA (country program and institutional analysis) index, is high.
10 Flawed 
institutions would be expected to produce limited and poor-quality health services. But Lewis 
(2006) finds no association between the effectiveness of health spending and proxy measures for 
the effectiveness of institutions in the health sector—either the government effectiveness or the 
corruption measures of Kaufmann, Kraay, and Mastruzzi (2005).  
 
One channel through which public spending may affect health—and one that, implicitly or 
otherwise, motivates some calls for greater spending—is its impact on the poor. Bidani and 
Ravallion (1997) find that public health spending significantly affects the health of the poor, but 
(consistent with Filmer and Pritchett 1999) not aggregate health.  
 
In more recent work, Boone and Zhan (2006) investigate the determinants of child mortality 
using survey data on 278,000 children in 45 low-income countries. Their results provide some 
nuances to those of Filmer, Hammer, and Pritchett (2000). Somewhat controversially, they find 
that the prevalence of common diseases and the supply of infrastructure such as water and 
sanitation are not good predictors of child mortality, but that parents’ education and a mother’s 
propensity to seek out modern medical care are. Here the simulated effects they report appear 
large: for example, they find that if all mothers and fathers in the 45 countries had years of 
schooling equal to those of parents in Egypt, child mortality in these countries would fall by 19 
percent. They also report that halving the prevalence of diarrhea, fever, and cough would reduce 
child mortality by only 3 percent.
11  
                                                 
10. This is good news as much for health spending as for the CPIA index as a measure of governance. “Good” 
public spending should lead to improved health outcomes (unless it simply crowds out private spending), so the fact 
that countries with high CPIA scores show a positive link from spending to health is consistent with the CPIA 
measuring something relevant. 
11. These numbers are, however, difficult to apply to decision making, as the costs of the two hypothetical 
interventions are not reported. 
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educated parents demand health services and that these services will be forthcoming from the 
private market. Educated parents may well be better able to induce a supply of quality medical 
care from the private market. They might even be better able, or better motivated, to ensure good 
governance procedures within the public sector, thereby improving both the quality of publicly 
delivered medical care and the reliability and adequacy of public infrastructure. 
 
In the OECD countries the evidence on the impact of health spending on health status is tenuous. 
Bunker, Frazier, and Mosteller (1994) suggest that the main effect of health care is on the quality 
of life and well-being, as measured by increases in activity and mobility. This indirect evidence 
suggests that health care plays a key role by providing information (about lifestyle and 
prevention) and reducing morbidity.  
 
Country-Level Evidence on the Effectiveness of Health Care Spending: The Importance of 
Institutions  
 
Examining why the link between health spending and health status is so tenuous is easiest at the 
country and health facility level, where institutional issues can be fully explored. Limited data 
and research on the subject complicate the design of effective policies, but evidence is beginning 
to emerge on the nature of health institutions in developing and transition countries and the kinds 
of services that they support. Our reading of the literature suggests that the more severe 
constraints on improving health through the delivery of health care in developing countries are 
institutional and include the provision and enforcement of basic performance incentives and cost 
containment. This section discusses some recent evidence on these topics and their relevance for 
institutional strengthening to improve health status.  
 
Access to health care has improved markedly in the last two decades, but the quality of public 
health care services has been examined only recently. For the most part it has been found 
wanting. Recent evidence suggests that ineffective incentives and lack of accountability 
undermine the public provision of health services, leading to underperformance and substandard 
care (Lewis 2006). This may help to explain why public spending shows minimal effects on 
health status. Jack and Lewis (2004) attribute the shortcomings to government failure, effectively 
“government interventions that have gone wrong.”  
 
Institutions in health care are important but understudied. The lack of sound institutions 
undermines health investments and leads to ambiguous evidence on the relationship between 
health care services and health status. Accepted indicators of health care performance such as 
hospital infection rates, utilization statistics, or surgery survival rates are rarely collected even 
where required, for lack of some combination of oversight, regulation, and enforcement. This 
applies in middle-income countries as well as poorer ones. Indirect indicators of poor 
performance that are increasingly relied on in the absence of more direct measures include 
provider absenteeism, lack of basic medical supplies and drugs, poor management of purchases, 
corruption in selling public positions, leakage of funds, and under-the-table payments by 
patients, all of which highlight the nature of the performance lapses that undermine effective 
service delivery (Lewis 2006).  
  27An extraordinarily important factor in public health care is simply whether workers show up for 
work. Chaudhury and Hammer (2004) report shockingly high rates of absenteeism among 
doctors in rural Bangladesh: 40 percent of doctors in large clinics and fully 74 percent of doctors 
in small (single-doctor) clinics were absent. Chaudhury and others (2005) report figures on the 
absenteeism of health workers and teachers across six developing countries (Bangladesh, 
Ecuador, India, Indonesia, Peru, and Uganda). Figure 8 summarizes evidence from these studies 
and others that show similarly high rates of absence using different methods including surprise 
visits, time-in-motion studies, and clinical observations. Absenteeism has been captured in 
qualitative work as well (DiTella and Savedoff 2001). 
 
Figure 8. Absentee Rates among Health Workers in Select Countries, 1989–2003 
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Results from a range of countries—India, Tanzania, and Brazil—are instructive. A study in India 
finds that the public sector provides medical practitioners with attenuated incentives for good 
performance: Das and Hammer (2007) report the results of observing more than 4,000 doctor-
patient interactions in Delhi and comparing clinical practices with what the doctor knew to be 
appropriate behavior (as appraised in previous vignettes).
12 They find that “public doctors exert 
much less effort than their private counterparts” (Das and Hammer 2007: 8). In addition, better-
trained doctors do not necessarily provide better service: Das and Hammer find that, although 
providers without medical degrees are less competent (that is, they know less about what should 
be done in clinical situations), providers with medical degrees exert significantly less effort. 
Indeed, “clearly incentives are strong for MBBS [that is, degree-holding] doctors to do less than 
they know, and [they are] stronger still in the public sector.” 
 
                                                 
12. Vignettes are case studies that assess adherence to clinical protocols. 
  28In Tanzania, using vignettes and direct clinical observation, Leonard and Masatu (2006) show 
that NGO physicians consistently provide more accurate diagnoses and better treatment than 
their public sector colleagues. The main differences are that NGOs charge more and exhibit 
better management, incentives, and accountability. These authors’ results suggest that 
performance is better where facility directors have greater authority, particularly the ability to 
hire and fire staff and adjust compensation. Leonard and Masatu (2007) indicate that in rural 
Tanzania a physician’s training has little effect on performance once the ownership of the 
provider is taken into account: what counts is not what you know but what you do, and the two 
are unrelated where incentives are not in place to encourage the application of medical 
knowledge. 
 
In Brazil, a recent experiment in hospital autonomy in 12 general public hospitals in the state of 
São Paulo led to significantly higher productivity of staff, more care, lower infection rates, 
reduced mortality, and lower costs when compared to a set of 12 traditionally managed general 
public hospitals of the same size in other similar locations. The ability to contract and terminate 
staff and to initiate efficiency measures provided powerful incentives for better hospital 
performance. Hospital directors who did not improve under the pilot project had their 
appointments terminated. Monthly tracking of performance led to impressive improvements in 
both quality and efficiency in hospitals where the ability to terminate both staff and management 
appointments provided accountability to the state funding agency (La Forgia and Couttolenc 
2008).  
 
The evidence from India, Tanzania, and Brazil highlights the critical roles of incentives, 
supervision, and accountability in raising performance and ensuring that expenditures will have 
positive returns in enhancing the health status of patients. Lewis (2006) summarizes a wealth of 
complementary evidence on issues of financing and delivery of care, identifying shortcomings 
and their measurement and emphasizing the importance of incentives and accountability if health 
institutions are to contribute effectively to improving health status and individual well-being.  
 
One response to poor performance in public facilities is to shift the focus to private actors, but as 
Das and Hammer (2007) illustrate, this is by no means a panacea in service delivery, for the 
reasons discussed above. At the same time, adverse selection problems in the insurance market 
can lead to a breakdown in private insurance coverage as the unhealthy and the poor are 
excluded. In this case, some form of mandatory insurance coverage, even if privately provided 
and financed, may be necessary to avert an adverse selection spiral. This is the approach taken in 
Chile, Colombia, Switzerland, and, more recently, the U.S. state of Massachusetts. In all of these 
cases, and others, the government regulates the private purchase of insurance by people earning 
middle and upper incomes, while subsidizing coverage for the poor, who would otherwise be 
unable to comply with the insurance mandate.  
 
To sum up, if health care spending is to improve health status, institutions matter. The systemic 
problems are increasingly well understood, but without shifts in the institutions and the 
incentives for performance embedded in them, the link between spending and outcomes is likely 
to remain weak. 
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The impacts of a population’s health on national income are hotly debated, and they probably 
vary depending on the health indicator used and the countries included in the analysis. Some 
cross-country regressions using instrumental variables find quite large impacts of health on 
income, but few other analytical approaches yield similar results. Part of the problem in 
resolving the debate lies in the fact that comparisons of health and nonhealth interventions in 
nonexperimental environments are besieged by identification problems, while (quasi) 
experimental settings that would allow such comparisons are especially rare. It is difficult 
enough to estimate the impact of a health or growth intervention compared with the status quo, 
but comparing health and growth interventions has proven especially intractable, particularly in 
light of the vast array of interventions that are feasible in both areas.  
 
The two empirical approaches to this dilemma have been, first, to estimate the effects of 
arguably exogenous innovations in population health status on incomes at the macro level and, 
second, to focus at the micro level on the impact of specific health interventions on economic 
outcomes.  
 
At the macro level, our tentative conclusion is that the effect of health on income is small if it 
exists at all and that the results are ambiguous, largely because of the methodological challenges 
discussed above. National public health investments such as environmental cleanup or 
vaccinations show an impact on overall health status and are associated with improved 
investment opportunities that contribute to growth. At the micro level, clear causal relationships 
have been documented from health to earning potential and income.  
 
Although the macro analyses seek to provide information on the impacts of improved health on 
aggregate incomes, they cannot really tell us whether an extra dollar of public funding should be 
allocated to the health sector or to an alternative or which interventions provide the biggest bang 
to health and income for the buck. Our reading of the literature suggests that some health 
policies and investments, particularly those with pure public-good attributes, can plausibly have 
important impacts on incomes, but that at the macro level health and incomes are at least as 
likely to be jointly determined by such intangible features as institutional quality, corruption, and 
public sector accountability. 
 
Nevertheless, micro studies provide solid guidance on marginal benefits and on some of the 
tradeoffs across investments at the individual and household levels. Factors that foster greater 
productivity and higher wages are nutrition, early childhood education (both cognitive and 
noncognitive), education more generally, and mother’s education in particular. Public health 
investments that eliminate pathogens raise health status and expand access to agricultural land, 
translating into enhanced learning and rising agricultural yields, respectively, and serving to raise 
productivity, labor supply, and earnings. Much remains to be done, however, on ensuring the 
benefits of medical interventions and investing to improve their effectiveness and impact.  
 
The lack of clarity about the macroeconomic link from health to economic growth is not a reason 
to refocus public investment away from the health sector. The link from growth to health itself 
takes many forms, and it would seem to be a mistake to put all our eggs in the growth basket if 
  30we care about health for its own sake. The more pressing problem is to improve the link from 
health spending to health outcomes: scarce resources allocated to the health sector that have little 
impact on health are very unlikely to have the knock-on effect on incomes that some scholars 
and advocates seek. Even if it turns out that there is little effect on growth, the improvements in 
health status will be worth the effort. 
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